Key points are not available for this paper at this time.
This document provides the 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
No takes yet. Share an insight, caveat, or question.
Valgimigli et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Dual antiplatelet therapyMore from European Heart Journal